Biodexa Pharmaceuticals (BDRX) Share-based Compensation (2019 - 2021)
Biodexa Pharmaceuticals (BDRX) reported Share-based Compensation of $51410.9 for Q3 2021, up 108.63% on a YoY basis from $24642.0 in Q3 2020, and up 108.23% sequentially from -$624573.3 in Q4 2020.
Biodexa Pharmaceuticals (BDRX) Share-based Compensation (2019 - 2021) Analysis & Trends
Biodexa Pharmaceuticals (BDRX) has 3 years of Share-based Compensation data on file, last reported at $51410.9 in Q3 2021.
- For the quarter ending Q3 2021, Share-based Compensation rose 108.63% year-over-year to $51410.9; the trailing twelve-month figure through Sep 2021 stood at -$1.1 million (changed N/A YoY), and the FY2025 full-year result was $224146.8, down 38.29% from the prior year.
- Share-based Compensation climbed to $51410.9 in Q3 2021, from -$624573.3 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $51410.9 in Q3 2021 to a low of -$624573.3 in Q4 2020.
- A 3-year average of -$245083.0 and a median of -$90041.9 in 2019 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation plunged 1968.37% in 2020 and surged 108.63% in 2021, its largest moves.
- Tracing BDRX's Share-based Compensation over 3 years: stood at $33428.8 in 2019, then sank by 1968.37% to -$624573.3 in 2020, then surged by 108.23% to $51410.9 in 2021.
- Business Quant data shows BDRX's Share-based Compensation at $51410.9 in Q3 2021, -$624573.3 in Q4 2020, and -$595639.6 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 305,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 9.26 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 87.30 Mn |
| 10 | Biodexa Pharmaceuticals | 17.56 Bn | 17.54 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 17, 2021 | 51,410.94 |
| Sep 17, 2021 | 51,410.94 |
| Dec 31, 2020 | -624,573.32 |
| Dec 31, 2020 | -624,573.32 |
| Sep 10, 2020 | -595,639.61 |
| Sep 10, 2020 | -595,639.61 |
| Dec 31, 2019 | 33,428.85 |
| Dec 31, 2019 | 33,428.85 |
| Jun 30, 2019 | -90,041.88 |
| Jun 30, 2019 | -90,041.88 |